Ron HN van Schaik - Concepedia

Author

Ron HN van Schaik

Also Known As

Guido Jenster, Patrinos, George P, R H van Schaik, R. H van Schaik, R. H. VAN SCHAIK, R. H. Van Schaik, R. H. van Schaik, R.H. Van Schaik, R.H. van Schaik, Ron H N van Schaik

139

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam University of Patras UCLouvain Radboud University Nijmegen

About

Ron HN van Schaik is an author at Erasmus MC specializing in medicine, pharmacology, and pharmacogenomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	735
2	Engineering	2	2	294
3	Public Health	2	2	253
4	Health Sciences	1	1	15
5	Allergy	1	1	15

Ron HN van Schaik

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and Tamoxifen Therapy Matthew P. Goetz, Katrin Sangkuhl, Henk‐Jan Guchelaar, Clinical Pharmacology & Therapeutics	2018	311
CYP3A5 Variant Allele Frequencies in Dutch Caucasians Ron HN van Schaik, Ilse P. van der Heiden, John N. van den Anker, Clinical Chemistry	2002	302
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients Marzia Del Re, Elisa Biasco, Stefania Crucitta, European Urology UrologyEngineeringCancer GenomicsHormonal TherapyProstatic Disease	2016	279
A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients Laure Elens, Rachida Bouamar, Dennis A. Hesselink, Clinical Chemistry	2011	240
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics Clint Mizzi, Eleni Dalabira, Judit Kumuthini, PLoS ONE Genetic EpidemiologyGenome-wide Association StudyBiomarker (Medicine)Pharmacogenomics BiomarkersBiostatistics	2016	153
Effect of a New Functional<i>CYP3A4</i>Polymorphism on Calcineurin Inhibitors‘ Dose Requirements and Trough Blood Levels in Stable Renal Transplant Patients Laure Elens, Ron HN van Schaik, Nadtha Panin, Pharmacogenomics	2011	151
Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients Violette Gijsen, Seema Mital, Ron HN van Schaik, The Journal of Heart and Lung Transplantation Pediatric Heart RecipientsTransplantationPediatric Heart DiseaseTransplantation MedicinePediatrics	2011	102
The risk of overanticoagulation in patients with cytochrome P450 CYP2C92 or CYP2C93 alleles on acenocoumarol or phenprocoumon Loes E. Visser, M. van Vliet, Ron HN van Schaik, Pharmacogenetics ThrombosisMedicineCytochrome P4502c9HematologyGenetic Epidemiology	2003	100
Personalized Pharmacogenomics Profiling Using Whole-Genome Sequencing Clint Mizzi, Brock A. Peters, Christina Mitropoulou, Pharmacogenomics	2014	99
Practical Recommendations for Pharmacogenomics-based Prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics Laurent Becquemont, Ana Alfirevic, Ursula Amstutz, Pharmacogenomics	2010	98

Page 1